BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Emkay Recommends Buy On Cadila Healthcare
Emkay has recommended buying Cadila Healthcare for traget price of Rs 655. "Cadila has entered into an agreement to sell its animal healthcare business to Zenex Animal Health India through a slump sale for a total consideration of Rs 2,900 crore. Zenex Animal Health India is an SPV controlled by Multiples Alternate Asset Management, Canada Pension Plan Investment Board and Rare Enterprises. The transaction is expected to be earnings neutral and will be completed in 90 days, subject to shareholders' approval," Emkay said in a report.